November 20, 2015
Clozapine REMS deadlines for prescribers and pharmacies extended
The prescriber certification deadline for new Clozapine REMS Program has been extended from November 23 to December 14. Due to…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
November 20, 2015
FDA advices not to use XForMan Plus
The Food and Drug Administration (FDA) has issued a notice in which it advises consumers not to purchase or use XForMan Plus,…
November 19, 2015
FDA nods to Narcan nasal spray-used to stop opioid overdose
The U.S. Food and Drug Administration approved Narcan nasal spray on Wednesday. Narcan is the first FDA-approved nasal spray version of…
November 19, 2015
Lilly and Merck move on with oncology clinical trial of and Keytruda
Eli Lilly and Merck are moving on with an existing oncology clinical trial collaboration to evaluate the safety and efficacy of the combination of Lilly’s Almita (pemetrexed for injection) and Merck’s Keytruda (pembrolizumab) in a pivotal Phase III study in first-line nonsquamous non-small cell lung cancer (NSCLC).
November 19, 2015
Sanofi CEO: Health must be part of the Climate debate
Sanofi will participate to Solutions COP21, the United Nations conference on climate change, as an official partner, a public exhibition in Paris.
November 19, 2015
Biofrontera concludes clinical phase III of BCC study. Approval of Ameluz expected in 2016
Biofrontera has concluded the clinical phase 3 of BCC study as the last patient in the ongoing phase has had its final clinical visit.
November 19, 2015
American Medical Association calls for ban on direct to consumer advertising of RX drugs and medical devices
The United States and New Zealand are the only two countries in the world that allow direct-to-consumer advertising of prescription drugs.
November 19, 2015
Strides Arcolab Limited becomes Strides Shasun Limited
India-headquartered pharmaceutical company, Strides Arcolab Limited has change its name to Strides Shasun Limited.
November 19, 2015
Indian IOLCP boosts Ibuprofen plant capacity
IOLCP has completed its De-bottlenecking/ Re-engineering project for its Ibuprofen Manufacturing facilities at Barnala with project cost of Rs 24 Crores, and has started the enhanced production from Thursday.
November 18, 2015
Health Canada to review Janssen’s NDS for daratumumab for Multiple Myeloma
Health Canada has accepted for review Janssen’s new drug submission (NDS) for daratumumab for treatment of Multiple Myeloma.